Search results
Results from the WOW.Com Content Network
Together, atypical lipomatous tumors (ALTs) and well-differentiated liposarcomas ... PLS survival rates at 1, 3, and 5 years are reported to be 93%, 75%, and 29% ...
Atypical lipomatous tumor; Dermatofibrosarcoma protuberans (includes pigmented varieties) ... Pediatric rhabdomyosarcoma patients have a 50–85% long term survival rate.
Atypical lipomatous tumors (ALTs) are a type of well-differentiated liposarcoma. The term ALT is often applied to tumors located in surgically accessible locations such as the skin, oral cavity , or eye socket whereas the term well-differentiated liposarcomas is applied to tumors in less surgically accessible, deep, and centrally-located, soft ...
Post-treatment local recurrences and metastases were observed in 15% and 38% of cases; 5- and 10-year overall survival rates were 60% and 48%, respectively; Overall median survival time were 10.1 years; and patients with tumors ≥10 cm in longest diameter had an almost 6-fold higher rate of developing metastases than patients with tumors 4 cm ...
In 1993, a genetic polymorphism within lipomas was localized to chromosome 12q15, where the HMGIC gene encodes the high-mobility-group protein isoform I-C. [2] This is one of the most commonly found mutations in solitary lipomatous tumors but lipomas often have multiple mutations. Reciprocal translocations involving chromosomes 12q13 and 12q14 ...
As with endometrial carcinomas, the prognosis is influenced by the grade and type of the adenocarcinoma, being poorest with serous differentiation. MMMTs are highly malignant; a stage I tumor has an expected five-year survival rate of 50%, while the overall five-year survival rate is less than 20%. [1] Staging of uterine MMMTs is as follows: [3]
In the United States during 2013–2017, the age-adjusted mortality rate for all types of cancer was 189.5/100,000 for males, and 135.7/100,000 for females. [1] Below is an incomplete list of age-adjusted mortality rates for different types of cancer in the United States from the Surveillance, Epidemiology, and End Results program.
Desmoplastic small-round-cell tumor (DSRCT) is an aggressive and rare cancer that primarily occurs as masses in the abdomen. [4] Other areas affected may include the lymph nodes, the lining of the abdomen, diaphragm, spleen, liver, chest wall, skull, spinal cord, large intestine, small intestine, bladder, brain, lungs, testicles, ovaries, and the pelvis.